TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

National Framework Agreement for Adalimumab Injection 1 April 2023

Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published4
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "National Framework Agreement for Adalimumab Injection 1 April 2023". Published status: complete. Published value: Value not published. 4 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS EnglandScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
46.5Bids / Report
6.4% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 881 active published awards; 872 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published24 Mar 2023, 11:45 GMT
Last source update24 Mar 2023, 11:45 GMT
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
UK
OCIDocds-h6vhtk-037c6c
What is being bought
Project Title: NHS National Framework Agreement for the supply of Adalimumab Injection commencing 1 April 2023<br/> <br/>Offer reference number: CM/PHR/22/5660<br/> <br/>CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab Injection to South of England. Period of framework: 1 April 2023 to 31 August 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months<br/>CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab Injection to the Midlands and East. Period of framework: 1 April 2023 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months<br/>CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab Injection to London. Period of framework: 1 April 2023 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months<br/>CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab Injection to North of England. Period of framework: 1 April 2023 to 28 February 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
What changed
From the official release history
  1. tender value changed
    24 Mar 2023, 11:45 GMT
  2. Status changed to complete
    24 Mar 2023, 11:45 GMT
  3. Official notice release published
    24 Mar 2023, 11:45 GMT
  4. Submission deadline changed to published date
    24 Mar 2023, 11:45 GMT
  5. Published value updated to £478,880,000
    26 Oct 2022, 15:03 BST
  6. Status changed to active
    26 Oct 2022, 15:03 BST
  7. Official notice release published
    26 Oct 2022, 15:03 BST
  8. Submission deadline changed to 28 Nov 2022, 13:00 GMT
    26 Oct 2022, 15:03 BST
  9. Buyer information updated
    26 Oct 2022, 15:03 BST
Lots and requirements (4)
Published by the contracting authority
  • Lot 1 · #1
    CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab
    cancelled
    Published valueNot published
    Lot 1 - CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab Injection to South of England. Period of framework: 1 April 2023 to 31 August 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #2
    CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab
    cancelled
    Published valueNot published
    Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab Injection to the Midlands and East. Period of framework: 1 April 2023 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 3 · #3
    CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab
    cancelled
    Published valueNot published
    Lot 3 - CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab Injection to the London. Period of framework: 1 April 2023 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 4 · #4
    CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab
    cancelled
    Published valueNot published
    Lot 4 - CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab Injection to the North of England. Period of framework: 1 April 2023 to 28 February 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    24 Mar 2023, 11:45 GMT
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Award active
    Not published · Not published
  7. Award active
    Not published · Not published
  8. Contract active
    Signed 14 Mar 2023, 00:00 GMT · £1
  9. Contract active
    Signed 14 Mar 2023, 00:00 GMT · £1
  10. Contract active
    Signed 14 Mar 2023, 00:00 GMT · £1
  11. Contract active
    Signed 14 Mar 2023, 00:00 GMT · £1
  12. Contract active
    Signed 14 Mar 2023, 00:00 GMT · £1
  13. Contract active
    Signed 14 Mar 2023, 00:00 GMT · £1
Commercial outcome and competition
Awards
Amgen Ltd
Not published · Not published · active
Sandoz Ltd
Not published · Not published · active
Biogen
Not published · Not published · active
Abbvie Ltd
Not published · Not published · active
Fresenius Kabi Limited
Not published · Not published · active
Celltrion Healthcare United Kingdom Limited
Not published · Not published · active
Contracts
Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab
£1 · signed 14 Mar 2023, 00:00 GMT · active
Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab
£1 · signed 14 Mar 2023, 00:00 GMT · active
Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab
£1 · signed 14 Mar 2023, 00:00 GMT · active
Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab
£1 · signed 14 Mar 2023, 00:00 GMT · active
Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab
£1 · signed 14 Mar 2023, 00:00 GMT · active
Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab
£1 · signed 14 Mar 2023, 00:00 GMT · active
Bid statistics
bids: 7 (lot 2)
bids: 7 (lot 2)
bids: 7 (lot 2)
bids: 7 (lot 2)
bids: 7 (lot 2)
bids: 7 (lot 2)
electronicBids: 7 (lot 2)
electronicBids: 7 (lot 2)
electronicBids: 7 (lot 2)
electronicBids: 7 (lot 2)
electronicBids: 7 (lot 2)
electronicBids: 7 (lot 2)
foreignBidsFromEU: 7 (lot 2)
foreignBidsFromEU: 7 (lot 2)
foreignBidsFromEU: 7 (lot 2)
foreignBidsFromEU: 7 (lot 2)
foreignBidsFromEU: 7 (lot 2)
foreignBidsFromEU: 7 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
smeBids: 1 (lot 2)
smeBids: 1 (lot 2)
smeBids: 1 (lot 2)
smeBids: 1 (lot 2)
smeBids: 1 (lot 2)
smeBids: 1 (lot 2)
Buyer and organisations in this procedure

NHS England

Contracting authority GB-FTS-3022
View buyer profile

  • NHS England
    buyer
    centralPurchasingBody

    Quarry House, Quarry Hill, Leeds, UK, LS2 7UE
    katie.noonan@nhs.net

  • Abbvie Ltd
    supplier

    08004972
    Abbvie House, Vanwall Business Park, Vanwall Road,, Maidenhead, Berks., UK, SL6 4UB

  • Amgen Ltd
    supplier

    2354269
    216 Science Park Milton Road, Cambridge, UK, CB4 0WA

  • Biogen
    supplier

    01497267
    Innovation House 70 Norden Road, Maidenhead Berkshire, UK, SL6 4AY

  • Celltrion Healthcare United Kingdom Limited
    supplier

    11685363
    The Switch ,1-7 The Grove,, Slough, UK, SL1 1QP

  • Fresenius Kabi Limited
    supplier

    2182135
    Cestrian Court, Eastgate Way, Manor Park,, Runcorn, Cheshire,, UK, WA7 1NT

  • Sandoz Ltd
    supplier

    01547204
    Park View, Riverside Way, Watchmoor Park,, Camberley, Surrey., UK, GU15 3YL

  • The High Court
    reviewBody

    The Strand, London, WC2A 2LL
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published